TERBUTALINE VIATRIS 5 mg/2 ml, solution for inhalation by nebulizer in a single-dose container 20 single-dose containers of 2 ml
Active ingredients: Terbutaline sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation by nebulizer20 single-dose containers of 2 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TERBUTALINE VIATRIS 5 mg/2 mL, solution pour inhalation par nébuliseur en récipient unidose
- Pharmaceutical form
- solution pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 20 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 2 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63274566CIP72688710CIP133400926887100Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE TERBUTALINEsolution | 5 mg · un récipient unidose de 2 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.